Evidence map›Paper›PMID 31088189›Full record

ArticleJournal of the American Heart Association2019

New Strategies for the Conduct of Clinical Trials in Pediatric Pulmonary Arterial Hypertension: Outcome of a Multistakeholder Meeting With Patients, Academia, Industry, and Regulators, Held at the European Medicines Agency on Monday, June 12, 2017.

Cécile Ollivier, Haihao Sun, Wayne Amchin, Maurice Beghetti, Rolf M F Berger, Stefanie Breitenstein, Christine Garnett, Ninna Gullberg, Patrik Hassel, Dunbar Ivy and 9 more

Open access · goldAbstract readConsensus Statement
In one paragraph

Article in Journal of the American Heart Association, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 38 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Twenty-Year Experience and Outcomes in a National Pediatric Pulmonary Hypertension Service.American journal of respiratory and critical care medicine · 2022
    Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 13 institutions in 7 countries.

Cécile Ollivier1 European Medicines Agency London United Kingdom.
Haihao Sun2 Food and Drug Administration Silver Spring MD.
Wayne Amchin2 Food and Drug Administration Silver Spring MD.
Maurice Beghetti3 Pediatric Cardiology Unit Centre Universitaire de Cardiologie et Chirurgie Cardiaque Pédiatrique University Hospitals of Geneva City of Geneva Switzerland.
Rolf M F Berger4 Center for Congenital Heart Diseases Department of Pediatric Cardiology Beatrix Children's Hospital University Medical Center Groningen University of Groningen the Netherlands.
Stefanie Breitenstein5 Bayer AG, Pharmaceuticals, Research and Development Wuppertal Germany.
Christine Garnett2 Food and Drug Administration Silver Spring MD.
Ninna Gullberg1 European Medicines Agency London United Kingdom.
Patrik Hassel6 PH Sweden Göteborg Sweden.
Dunbar Ivy7 Heart Institute Children's Hospital Colorado University of Colorado School of Medicine Aurora CO.
Steven M Kawut8 Perelman School of Medicine University of Pennsylvania Philadelphia PA.
Agnes Klein9 Health Canada Ottawa Ontario Canada.
Catherine Lesage10 Actelion Pharmaceuticals Ltd Allscwil Switzerland.
Marek Migdal11 Childrens Memorial Health Institute Warsaw Poland.
Barbara Nije9 Health Canada Ottawa Ontario Canada.
Michal Odermarsky12 Department of Paediatric Cardiology Paediatric Heart Center Lund University and Skåne University Hospital Lund Sweden.
James Strait13 MSD Lucerne Switzerland.
Pieter A de Graeff14 Medicines Evaluation Board Utrecht the Netherlands.
Norman Stockbridge2 Food and Drug Administration Silver Spring MD.
Center for Drug Evaluation and Research · USHealth Canada · CAActelion (Switzerland) · CHBayer (Germany) · DEChildren's Memorial Health Institute · PLMedicines Evaluation Board · NLMSD (Switzerland) · CHSkåne University Hospital · SEUnited States Food and Drug Administration · USUniversity Hospital of Geneva · CHUniversity of Colorado Denver · USUniversity of Groningen · NLUniversity of Pennsylvania · US

Funding

Mentored Patient-Oriented Research in Pulmonary Arterial HypertensionK24HL103844 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI KAWUT, STEVEN M · 2011 to 2020
$1.6M
NHLBI NIH HHS K24 HL103844
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Drug ApprovalPatientsPatient SelectionResearch PersonnelResearch SubjectsStakeholder ParticipationAge FactorsAntihypertensive AgentsClinical Trials as TopicCooperative BehaviorHumansPatient SafetyPublic-Private Sector PartnershipsPulmonary Arterial HypertensionRisk AssessmentRisk FactorsAntihypertensive Agentspatient‐reported outcomepediatricspharmacologyresearch ethicsresearch method

Identifiers

PMID31088189
PMCPMC6585335
OpenAlexW2945317060

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.